SARS-CoV-2 is predominantly a respiratory disease that spreads primarily through direct contact (droplets, person to person). However, gastrointestinal (GI) symptoms such as vomiting, nausea, diarrhoea, and abdominal pain are becoming more often recognised as COVID-19 symptoms. Other symptoms of COVID-19, such as dysgeusia and anosmia, have also become more well-known. Studies have also found that these GI symptoms are frequently an early manifestation of Covid-19 and hence a strong predictor of the virus's emergence. There are still many unanswered questions and challenges, such as the relevance of virus detection in asymptomatic subjects' stool/rectal swabs, whether ACE2 is a direct mediator for SARS-CoV-2 entry into the GI tract, and how the virus might survive passage through the digestive system's extreme pH environment. As a result, it's critical to see Covid-19 as more than a respiratory disease and to identify approaches to manage the disease's gastrointestinal component.
Title : Gastroenterology viewed through a glass darkly: An IDI perspective
Gilles R G Monif, University of Florida, United States
Title : The psychology of disorders of gut-brain interactions
Tracy E Hill, Ph.D. & Associates LLC, United States
Title : How epigastric impedance would radically change gastric medicine
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Role of Pregnancy (P) and breastfeeding on Gallstones (GS) related Acute Pancreatitis (AP)
Alberto Maringhini, La Maddalena, Italy
Title : From the birth of atoms to life: Iodine and caesium, angels and demons of evolutionary biology, in pancreatic cancer and diabetes
Venturi Sebastiano, AUSL-ROMAGNA, Italy
Title : The IL17REL gene encodes a decoy receptor of IL-17 family cytokines to control gut inflammation
Youcun Qian, Shanghai Institute of Nutrition and Health, China